154 related articles for article (PubMed ID: 6098481)
1. Interaction of dopamine receptor ligands with subtypes of the opiate receptor.
Boublik JH; Funder JW
Eur J Pharmacol; 1984 Dec; 107(1):11-6. PubMed ID: 6098481
[TBL] [Abstract][Full Text] [Related]
2. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
3. Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain.
Titeler M; Lyon RA; Kuhar MJ; Frost JF; Dannals RF; Leonhardt S; Bullock A; Rydelek LT; Price DL; Struble RG
Eur J Pharmacol; 1989 Aug; 167(2):221-8. PubMed ID: 2556284
[TBL] [Abstract][Full Text] [Related]
4. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
Chang KJ; Hazum E; Cuatrecasas P
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
[TBL] [Abstract][Full Text] [Related]
5. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
Tam SW; Cook L
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5618-21. PubMed ID: 6147851
[TBL] [Abstract][Full Text] [Related]
6. [Stability of opiate receptors of wet and lyophilized preparations of rat brain membranes].
Zaĭtsev SV; Kurochkin IN; Sergeeva MG; Varfolomeev SD
Biokhimiia; 1984 Jul; 49(7):1127-33. PubMed ID: 6089917
[TBL] [Abstract][Full Text] [Related]
7. Morphiceptin: biphasic inhibition of mu-opiate receptor ligands.
Villiger JW
Pharmacol Biochem Behav; 1984 Nov; 21(5):705-6. PubMed ID: 6096895
[TBL] [Abstract][Full Text] [Related]
8. Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands.
Pfeiffer A; Herz A
Eur J Pharmacol; 1982 Feb; 77(4):359-61. PubMed ID: 6277680
[TBL] [Abstract][Full Text] [Related]
9. [Alpha interferon interaction with opiate receptors in the rat brain].
Panchenko LF; Aliab'eva TN; Malinovskaia VV; Balashov AM
Biull Eksp Biol Med; 1987 Jul; 104(7):87-9. PubMed ID: 3040148
[TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
Kooper GN; Levinson NR; Copeland CF; Bowen WD
Mol Pharmacol; 1988 Mar; 33(3):316-26. PubMed ID: 2832721
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of humoral endorphin on the binding of opiate agonists and antagonists.
Sarne Y; Itzhak Y; Keren O
Eur J Pharmacol; 1982 Jul; 81(2):227-35. PubMed ID: 6288405
[TBL] [Abstract][Full Text] [Related]
12. [Interaction of thymosin fraction 3 with opiate receptors].
Zozulia AA; Khomiakov IuN; Bezvershenko IA
Biull Eksp Biol Med; 1986 Mar; 101(3):298-300. PubMed ID: 3006826
[TBL] [Abstract][Full Text] [Related]
13. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
Rahmani NH; Gulati A; Bhargava HN
Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
[TBL] [Abstract][Full Text] [Related]
16. Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro.
Smith DJ; Bouchal RL; deSanctis CA; Monroe PJ; Amedro JB; Perrotti JM; Crisp T
Neuropharmacology; 1987 Sep; 26(9):1253-60. PubMed ID: 2823161
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
18. The interactions of 1-alkyl-4,4-diphenylpiperidines with opiate receptors.
Neuser D; Stasch JP; Witteler M; Kuhn W; Gerlach M; Jutzi P; Przuntek H
Eur J Pharmacol; 1983 Feb; 87(2-3):315-8. PubMed ID: 6301858
[TBL] [Abstract][Full Text] [Related]
19. Opiate receptor binding affected differentially by opiates and opioid peptides.
Childers SR; Creese I; Snowman AM; Synder SH
Eur J Pharmacol; 1979 Apr; 55(1):11-8. PubMed ID: 220062
[TBL] [Abstract][Full Text] [Related]
20. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
Ishizuka Y; Oka T
Tokai J Exp Clin Med; 1987 Mar; 12(1):11-7. PubMed ID: 2835832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
